Butyrylcholinesterase deficiency and its clinical importance in anaesthesia: a systematic review
- 1 January 2019
- journal article
- review article
- Published by Wiley in Anaesthesia
- Vol. 74 (4) , 518-528
Abstract
Summary: Butyrylcholinesterase deficiency prolongs the effects of the drugs it degrades; succinylcholine and mivacurium. Existing literature on butyrylcholinesterase deficiency is dominated by genetic and biochemical studies. We searched MEDLINE , Embase, Web of Science and Biosis to systematically review the causes and clinical consequences of butyrylcholinesterase deficiency. We considered outcomes clinically relevant if neuromuscular blockade, induced by succinylcholine or mivacurium, was assessed using clinical criteria or neuromuscular monitoring. We included 66 studies: 25 randomised controlled trials; 13 clinically controlled trials; 26 prospective observational studies; 1 retrospective study; and 1 qualitative study. Data heterogeneity precluded quantitative synthesis. Studies described genetic, physiological, acquired or pharmacologically induced causes of butyrylcholinesterase deficiency. The prolongation of neuromuscular blockade by butyrylcholinesterase deficiency was most pronounced with homozygosity of a genetic variant, but other more common factors included increasing age, pregnancy, severe liver disease, burn injuries and drug interactions.Keywords
This publication has 83 references indexed in Scilit:
- Response to Succinylcholine in Patients Carrying the K-Variant of the Butyrylcholinesterase GeneAnesthesia & Analgesia, 2013
- Practice Guidelines for Postanesthetic CareAnesthesiology, 2013
- Neuromuscular pharmacodynamics of mivacurium in adults with major burnsBritish Journal of Anaesthesia, 2011
- Postpartum Patients Have Slightly Prolonged Neuromuscular Block After MivacuriumAnesthesia & Analgesia, 1998
- Die neuromuskuläre und kardiovaskuläre Wirkung von Mivacurium bei der Narkoseeinleitung von Patienten mit NiereninsuffizienzAINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie, 1996
- Edrophonium requirements for reversal of deep neuromuscular block following infusion of mivacuriumCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1995
- Comparison of the effects of neostigmine and edrophonium on the duration of action of suxamethoniumActa Anaesthesiologica Scandinavica, 1995
- Association between life-threatening cocaine toxicity and plasma cholinesterase activityAnnals of Emergency Medicine, 1992
- Pretreatment with pancuronium before suxamethonium administration in patients heterozygous for the usual and the atypical plasma cholinesterase geneActa Anaesthesiologica Scandinavica, 1991
- The effect of bambuterol on plasma cholinesterase activity and suxamethonium‐induced neuromuscular blockade in subjects heterozygous for abnormal plasma cholinesteraseActa Anaesthesiologica Scandinavica, 1990